Amnioinfusion with preterm, premature rupture of membranes.
Excluding labor, the greatest risks to the fetus from preterm PROM are umbilical cord accidents and infection. Heretofore, the clinical options for the PROM patient have been limited. With the advent and refinement of amnioinfusion, the utility of expectant management may be greatly increased. Through the use of amnioinfusion or its permutations, a number of diagnostic and therapeutic procedures previously unavailable to the PROM patient may become routine, including amniotic fluid volume expansion and direct in utero prophylaxis/treatment of amnionitis.
Strong
T H
TH
Phoenix Perinatal Associates, Arizona.
D000650:Amnion; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002821:Chorioamnionitis / Q000188:drug therapy / Q000209:etiology; D000075202:Contraindications; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications / Q000628:therapy*; D006801:Humans; D007263:Infusions, Parenteral / Q000295:instrumentation / Q000379:methods*; D011247:Pregnancy; D012965:Sodium Chloride / Q000008:administration & dosage / Q000627:therapeutic use; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014470:Umbilical Cord / Q000293:injuries
D000900:Anti-Bacterial Agents; D013501:Surface-Active Agents; D012965:Sodium Chloride